(254 days)
Not Found
No
The summary describes a bioabsorbable bone fixation system made of HA/PLLA composites, with no mention of AI or ML technology in the device description, intended use, or performance studies.
Yes
The device is a bone fixation system indicated for use in trauma and reconstructive procedures of the craniofacial skeleton, which directly treats a medical condition.
No
The device is a bone fixation system used for trauma and reconstructive procedures, not for diagnosis.
No
The device description explicitly states that the device consists of sterile, single-use bone plates, meshes, and screws, which are physical hardware components.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health.
- Device Description: The OSTEOTRANS™-MX Bioabsorbable Bone Fixation System is described as bone plates, meshes, and screws used for fixing bone fractures and osteotomies. These are implanted devices used directly on the bone, not for testing samples.
- Intended Use: The intended use is for "trauma and reconstructive procedures in the craniofacial skeleton," which involves surgical intervention, not diagnostic testing.
The information provided clearly indicates this is a surgical implant device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The OSTEOTRANS™-MX Bioabsorbable Bone Fixation System is indicated for use in trauma and reconstructive procedures in the craniofacial skeleton, which includes the facial cranium, mid-face, maxilla and mandible.
Product codes (comma separated list FDA assigned to the subject device)
IEV, JEY
Device Description
The OSTEOTRANS™-MX Bioabsorbable Bone Fixation System devices are the sterile, single-use bone plates, meshes and screws manufactured from composites of hydroxyapatite and poly-L-lactide (HA/PLLA). Plates, meshes and screws are provided with various shapes and sizes typical of other marketed fixation devices.
Used properly, in the presence of adequate immobilization, the OSTEOTRANSMAN Bioabsorbable Bone Fixation System devices maintain accurate alignment of bone fractures and osteotomies.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
craniofacial skeleton, which includes the facial cranium, mid-face, maxilla and mandible
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance data demonstrate that the OSTEOTRANSTM-MX Bioabsorbable Bone Fixation System has the requisite strength and favorable degradation profile to provide sufficient and sustained bone fixation for intended uses.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K010352, K011569, K030069, K000694, K980927
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.4760 Bone plate.
(a)
Identification. A bone plate is a metal device intended to stabilize fractured bone structures in the oral cavity. The bone segments are attached to the plate with screws to prevent movement of the segments.(b)
Classification. Class II.
0
K06/881
1 of 2
MAR 1 4 2007
510(k) Summary OSTEOTRANS™-MX
Bioabsorbable Bone Fixation System
| Submitter's name : | Takiron Co., Ltd. |
|---|---|
| Submitter's address: | 3-13 Azuchi-machi 2-chome, Chuo-ku, Osaka |
| 541-0052, Japan | |
| Contact Person : | Kunihiro Hata |
| Regulatory Affairs Specialist | |
| 405 Nagano, Yasutomi-cho, Himeji, Hyogo, | |
| 671-2421, Japan | |
| Phone: +81 790 66 2411 | |
| Fax: +81 790 66 3717 | |
| Date prepared: | June 28, 2006 |
| Trade or proprietary name: | OSTEOTRANSTM-MX Bioabsorbable Bone |
| Fixation System | |
| Common or usual name: | Bone Fixation Plate and screw |
| Classification name: | Plate, Fixation, Bone , Class II |
| Device product code: | As shown in 21 CFR 872.4760 bone plates are |
| classified as Class II . Bone plates have been | |
| assigned Product Code IEV |
Establishment Registration Number:
Takiron Co., Ltd. has not yet obtained an Establishment Registration Number.
Legally Marketed Predicate Devices:
Inion CPSTM 1.5/2.0/2.5 Bioabsorbable Fixation System (K010352) BioSorbFXTM O/M 2.0/2.4 Bioabsorbable Fixation System (K011569) Synthes Poly (L-Lactide-co-Glycolide) Resorbable Fixation System (K030069) MacroPoreMX Mandibular Fixation System (K000694) LactoSorb Panels and Fasteners (K980927)
1
Intended Use:
The OSTEOTRANS™-MX Bioabsorbable Bone Fixation System is indicated for use in trauma and reconstructive procedures in the craniofacial skeleton, which includes the facial cranium, mid-face, maxilla and mandible.
Device Description:
The OSTEOTRANS™-MX Bioabsorbable Bone Fixation System devices are the sterile, single-use bone plates, meshes and screws manufactured from composites of hydroxyapatite and poly-L-lactide (HA/PLLA). Plates, meshes and screws are provided with various shapes and sizes typical of other marketed fixation devices.
Used properly, in the presence of adequate immobilization, the OSTEOTRANSMAN Bioabsorbable Bone Fixation System devices maintain accurate alignment of bone fractures and osteotomies.
Summary of Technology:
The OSTEOTRANS™-MX Bioabsorbable Fixation System has the same technological characteristics (i.e., design and material) when compared to the predicate devices. Performance data demonstrate that the OSTEOTRANSTM-MX Bioabsorbable Bone Fixation System has the requisite strength and favorable degradation profile to provide sufficient and sustained bone fixation for intended uses.
Substantial equivalence
ﺔ ﺍﻟﻤﺘﺤﺪﺓ
The OSTEOTRANS The MX Bioabsorbable Bone Fixation System is indicated for the same uses and anatomical regions as the predicate devices.
The OSTEOTRANS™-MX Bioabsorbable Bone Fixation System has very similar physical design features and functional characteristics as the predicate devices. Therefore the OSTEOTRANSTM-MX Bioabsorbable Bone Fixation System is substantially equivalent in design, materials and intended use and principles of operation to the predicate devices.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with three lines forming its body and wings. The eagle is facing to the right. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES, USA" is arranged in a circular pattern around the eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR 1 4 2007
Mr. Kunihiro Hata Regulatory Affairs Specialist Takiron Company, Limited 405 Nagano, Yasutomi-Cho Himeji, Hyogo JAPAN 671-2421
Re: K061881
Trade/Device Name: OSTEOTRANS™-MX Bioabsorbable Bone Fixation System Regulation Number: 872.4760 Regulation Name: Bone Plate Regulatory Class: II Product Code: JEY Dated: March 9, 2007 Received: March 9, 2007
Dear Mr. Hata:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Fedgral Register.
3
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
Carl
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
INDICATIONS FOR USE
Applicant: Takiron Co., Ltd. 510(k) Number (if known): __ K061881 Device Name: _ OSTEOTRANS™-MX Bioabsorbable Bone Fixation System
Indications For Use:
The OSTEOTRANS™-MX Bioabsorbable Bone Fixation System is indicated for use in trauma and reconstructive procedures in the craniofacial skeleton, which includes the facial cranium, mid-face, maxilla and mandible.
(Please do not write below this line-continue on another page if needed) Concurrence of CDRH, Office of Device Evaluation (ODE)
X Prescription Use_ Over-The-Counter Use_ OR (Per 21 CFR 801.109)
Susan Burns
1-2 1-2 1-1
111
fo6 188